Ring Therapeutics is a biotechnology company dedicated to developing a new class of gene therapies through the use of naturally occurring commensal viruses. Their pioneering approach focuses on creating re-doseable and targetable DNA medicines that utilize persistent, non-integrating vectors, addressing limitations seen in traditional gene therapies. With a commitment to innovation, Ring Therapeutics is working on a diverse pipeline of targeted treatments for diseases with significant unmet medical needs, leveraging cutting-edge technology to transform how genetic medicine can be applied in healthcare.